SciELO - Scientific Electronic Library Online

 
vol.62 issue5Lipid disorders among Black Africans non-users of lipid-lowering medicationInsulin autoimmune syndrome in an occidental woman: a case report and literature review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Archives of Endocrinology and Metabolism

Print version ISSN 2359-3997On-line version ISSN 2359-4292

Abstract

SOUSA-SANTOS, Francisco et al. Congenital hyperinsulinism in two siblings with ABCC8 mutation: same genotype, different phenotypes. Arch. Endocrinol. Metab. [online]. 2018, vol.62, n.5, pp.560-565. ISSN 2359-3997.  http://dx.doi.org/10.20945/2359-3997000000077.

Congenital hyperinsulinism (CHI) is a heterogenous disease caused by insulin secretion regulatory defects, being ABCC8/KCNJ11 the most commonly affected genes. Therapeutic options include diazoxide, somatostatin analogues and surgery, which is curative in focal CHI. We report the case of two siblings (born two years apart) that presented themselves with hypoketotic hyperinsulinemic persistent hypoglycemias during neonatal period. The diagnosis of diffuse CHI due to an ABCC8 compound mutation (c.3576delG and c.742C>T) was concluded. They did not benefit from diazoxide therapy (or pancreatectomy performed in patient number 1) yet responded to somatostatin analogues. Patient number 1 developed various neurological deficits (including epilepsy), however patient number 2 experienced an entirely normal neurodevelopment. We believe this case shows how previous knowledge of the firstborn sibling's disease contributed to a better and timelier medical care in patient number 2, which could potentially explain her better neurological outcome despite their same genotype.

        · text in English     · English ( pdf )